Possibility of non-invasive diagnosis of gastric mucosal precancerous changes

doi:10.3748/wjg.v10.i21.3146

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2969)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-7) series.

Item

Count

PDF

264

HTML

2354

Figures (1-1)

164

Tables (1-7)

187

Sum=2969

Nov 1, 2004 (publication date) through Nov 9, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

H Pylori

World J Gastroenterol. Nov 1, 2004; 10(21): 3146-3150
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3146

Possibility of non-invasive diagnosis of gastric mucosal precancerous changes

Victor D. Pasechnikov, Sergey Z. Chukov, Sergey M. Kotelevets, Alexander N. Mostovov, Varvara P. Mernova, Maria B. Polyakova

Victor D. Pasechnikov, Sergey M. Kotelevets, Alexander N. Mostovov, Department of Therapy, Medical Academy, Stavropol, Russian Federation

Sergey Z. Chukov, Varvara P. Mernova, Maria B. Polyakova, Department of Pathology, Medical Academy, Stavropol, Russian Federation

Author contributions: All authors contributed equally to the work.

Correspondence to: Professor Victor D. Pasechnikov, Aviatsionnaya street, 21, Stavropol, 355017, Russian Federation. passetchnikov@mail.ru

Telephone: +7-8652-354700

Received: March 11, 2004
Revised: April 2, 2004
Accepted: April 9, 2004
Published online: November 1, 2004

Abstract

AIM: To assess the possibility of non-invasive screening of atrophic chronic gastritis for preventing further development of gastric cancer.

METHODS: One hundred and seventy-eight consecutive Helicobacter pylori (H pylori)-positive dyspeptic patients after detection of serum levels of pepsinogen-1 (PG-1) and gastrin-17 (G-17) by enzyme immunoassay were proposed for endoscopy and histology. The serologic and morphologic results were compared with estimating the sensitivity, specificity and prognostic values of the tests.

RESULTS: There was statistically significant reverse dependence between the grade of stomach mucosal antral or corpus atrophy and the proper decreasing of serum G17 or PG1 levels. The serologic method was quite sensitive in the diagnosis of non-atrophic and severe antral and corpus gastritis. Also, it was characterized by the high positive and negative prognostic values.

CONCLUSION: Detection of serum G-17 and PG1 levels can be offered as the screening tool for atrophic gastritis. The positive serologic results require further chromoendoscopy with mucosal biopsy, for revealing probable progressing of atrophic process with development of intestinal metaplasia, dysplasia or gastric cancer.

Keywords: $[Keywords]